These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6865364)

  • 61. Correlation of VHI-10 to voice laboratory measurements across five common voice disorders.
    Gillespie AI; Gooding W; Rosen C; Gartner-Schmidt J
    J Voice; 2014 Jul; 28(4):440-8. PubMed ID: 24698885
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Differentiation of organic and functional voice disorders in slight adduction disorders of the larynx].
    Schutte HK
    HNO; 1984 Jan; 32(1):21-3. PubMed ID: 6706693
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Posterior cricoarytenoid myoplasty with medialization thyroplasty in the management of refractory abductor spasmodic dysphonia.
    Shaw GY; Sechtem PR; Rideout B
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):303-6. PubMed ID: 12731624
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Botulinum toxin injection for adductor spastic dysphonia: patient self-ratings of voice and phonatory effort after three successive injections.
    Aronson AE; McCaffrey TV; Litchy WJ; Lipton RJ
    Laryngoscope; 1993 Jun; 103(6):683-92. PubMed ID: 8502104
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Voiced Oral High-frequency Oscillation Technique's Immediate Effect on Individuals With Dysphonic and Normal Voices.
    Saters TL; Ribeiro VV; Siqueira LTD; Marotti BD; Brasolotto AG; Silverio KCA
    J Voice; 2018 Jul; 32(4):449-458. PubMed ID: 28844805
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Limbic and cortical control of phonation for speech in response to a public speech preparation stressor.
    Dietrich M; Andreatta RD; Jiang Y; Stemple JC
    Brain Imaging Behav; 2020 Oct; 14(5):1696-1713. PubMed ID: 31049806
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An evaluation of laryngeal muscle activation in patients with voice tremor.
    Koda J; Ludlow CL
    Otolaryngol Head Neck Surg; 1992 Nov; 107(5):684-96. PubMed ID: 1437206
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Non-organic dysphonia. II. A comparison of subglottal pressures in normal and pathological voices.
    Gramming P
    Acta Otolaryngol; 1989; 107(1-2):156-60. PubMed ID: 2929314
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rapid manual abilities in spasmodic dysphonic and normal female subjects.
    Cannito MP; Kondraske GV
    J Speech Hear Res; 1990 Mar; 33(1):123-33. PubMed ID: 2314070
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
    Bielamowicz S; Ludlow CL
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [An overview of the symptoms and signs of voice disorders and the pathophysiology of hoarseness].
    Milutinović Z
    Srp Arh Celok Lek; 1997; 125(3-4):106-9. PubMed ID: 9221516
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of voicing and syntactic complexity on sign expression in adductor spasmodic dysphonia.
    Erickson ML
    Am J Speech Lang Pathol; 2003 Nov; 12(4):416-24. PubMed ID: 14658993
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Validation of the Acoustic Voice Quality Index in the Japanese Language.
    Hosokawa K; Barsties B; Iwahashi T; Iwahashi M; Kato C; Iwaki S; Sasai H; Miyauchi A; Matsushiro N; Inohara H; Ogawa M; Maryn Y
    J Voice; 2017 Mar; 31(2):260.e1-260.e9. PubMed ID: 27287930
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
    Zwirner P; Murry T; Swenson M; Woodson GE
    Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Electrical activity of extrinsic laryngeal muscles in subjects with and without dysphonia.
    Balata PM; Silva HJ; Pernambuco LA; Amorim GO; Braga RS; Fernandes da Silva EG; Lima LM; Moraes SR
    J Voice; 2015 Jan; 29(1):129.e9-17. PubMed ID: 24962232
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessment of a method for the automatic on/off control of an electrolarynx via lip deformation.
    Wan C; Wu L; Wu H; Wang S; Wan M
    J Voice; 2012 Sep; 26(5):674.e21-30. PubMed ID: 22801245
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of expiratory effort on dysphonic patients on increasing vocal intensity.
    Makiyama K; Kida A; Sawashima M
    Otolaryngol Head Neck Surg; 1998 May; 118(5):723-7. PubMed ID: 9591881
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Blink reflex excitability recovery curves in patients with spasmodic dysphonia.
    Cohen LG; Ludlow CL; Warden M; Estegui M; Agostino R; Sedory SE; Holloway E; Dambrosia J; Hallett M
    Neurology; 1989 Apr; 39(4):572-7. PubMed ID: 2927683
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human laryngeal responses to auditory stimulation.
    Sapir S; McClean MD; Larson CR
    J Acoust Soc Am; 1983 Jan; 73(1):315-21. PubMed ID: 6826901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.